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Although colorectal cancer (CRC) is the third most common cancer in women, it is a rare malignancy in pregnancy. Symptoms
of CRC such as fatigue, malaise, nausea, vomiting, rectal bleeding, anemia, altered bowel habits, and abdominal mass are often
considered typical symptoms of pregnancy. Many cases of CRC are diagnosed in advanced stages due to missed warning signs
of CRC, which may be misinterpreted as normal symptoms related to pregnancy. This report reviews 2 cases of CRC diagnosed
within a 4-month interval at our institution. Both cases were initially thought to be atypical presentations of preeclampsia. Prenatal
history, hospital course, and postpartum course were reviewed for both patients. CRC is often diagnosed at advanced stages in
pregnancy. Common physiological symptoms of pregnancy should be scrutinized carefully and worked up appropriately, especially
if symptoms remain persistent or increase in intensity or severity.

1. Introduction
Colorectal cancer (CRC) has a reported incidence of 0.002%
in pregnancy [1]. The mean age of diagnosis of CRC in pregnancy is 31 years old [1]. Delayed childbearing and increased
maternal age are factors that may lead to an increased incidence of CRC complicating pregnancy [2].

2. Case Presentation
Case 1. A 34-year-old G4P2012 with a known medical history
of neurofibromatosis presented at 35-week gestation after a
fall with complaints of nausea, vomiting, and right upper
quadrant pain. Her nausea and vomiting improved with
hydration. The right upper quadrant pain was attributed to
musculoskeletal pain due to the fall. Laboratory evaluation
demonstrated an isolated, elevated aspartate aminotransferase of 117 U/L and she was discharged home after she
tolerated diet with subjective improvement in symptoms.

The patient returned 5 days later due to recurrent
right upper quadrant pain, headache, and contractions. The
patient’s contractions improved after terbutaline and pain
relief was achieved with fentanyl. Fetal status remained reassuring. HELLP laboratory studies were drawn and showed
the aspartate aminotransferase to be elevated to 166 U/L and
lactate dehydrogenase (LDH) elevated to 1546 𝜇kat/L. The
patient’s blood pressures remained normotensive; however,
an atypical presentation of preeclampsia was considered
given the elevated liver enzymes and symptomatology of
preeclampsia including headache and right upper quadrant
pain. A timed 24-hour urine protein was performed to rule
out atypical presentation of preeclampsia, which showed
340 mg of protein.
An abdominal ultrasound was obtained due to persistent
right upper quadrant pain and showed hepatomegaly with
the right hepatic lobe measuring 21 cm diagonally with
multiple confluent echogenic masses visualized within the
liver. The elevation of LDH was attributed to infiltration of
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the liver by hepatic lesions, contributing to hemolysis.
Magnetic resonance imaging (MRI) was recommended to
evaluate the ultrasound findings.
On day 2 of hospitalization, the patient had diarrhea and
continued to have sharp right upper quadrant pain. MRI
studies revealed near complete replacement of the liver by
innumerable hepatic masses, some of which demonstrated
central cystic changes which were thought to possibly represent neurofibromas or other tumors associated with neurofibromatosis given the patient’s history. Metastatic disease
was considered unlikely due to the lack of a T2 hyperintense
signal.
Ultimately, the decision was made to proceed to delivery
via cesarean section at 36-week gestation due to persistent
right upper quadrant pain and worsening of bilirubin and
LDH. A multidisciplinary operating team was organized with
gynecologic oncology and transplant surgery on standby
for exploration of the abdomen and evaluation of the liver
after delivery of the infant. At the time of surgery, a 4–
6 cm transverse colon mass was identified with extensive
tumor burden in both liver lobes (Figures 1 and 2). Two
core needle biopsies and 1 excisional biopsy were obtained.
Enlarged para-aortic lymph nodes were also appreciated.
Intraoperative consultation was made by surgical oncology
and the plan was to avoid removal of the transverse colon
mass, which would not benefit the patient from the disease
process and would put her at risk of an anastomotic leak.
Instead, a diverting loop colostomy was performed by general
surgery.
The postoperative course was uneventful. Hematology
oncology was consulted and carcinoembryonic antigen
(CEA) was obtained, which demonstrated elevation at
2131.5 𝜇g/L. The pathology report confirmed metastatic carcinoma of the colon. A computed tomography (CT) scan
was obtained of the chest, abdomen, and pelvis and was
negative except for the known masses of the liver and
colon. The patient was found to have stage IV colon cancer.
Genetic testing was obtained to evaluate the patient for Lynch
syndrome and other mutations contribute to premature colon
cancer. Gene mutation analysis showed positive Kras with
point mutation indicated by the nucleotide change in codon
12 and negative BRAF mutation. Microsatellite instability
testing showed normal expression of MLH1, MSH2, MSH6,
and PMS2 proteins without any altered markers. The patient
initiated FOLFOX 4 weeks after her operation.
Case 2. A 44-year-old gravida 3 para 2 presented to labor
and delivery triage due to severe contractions. Her prenatal
course was only significant for gestational diabetes, which was
controlled with glyburide, and back pain starting at 35 weeks,
for which the patient took acetaminophen with Codeine
number 3 on occasion to relieve her discomfort. The patient
was scheduled for repeat cesarean section at 39 weeks due to a
prior history of 2 cesarean sections. The patient was found to
be in labor and underwent an uncomplicated repeat cesarean
section with bilateral tubal ligation.
On postoperative day 2, the patient was noted to be hypertensive in the range of 147–161/83–101 mmHg, which was
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Figure 1: Transverse colonic mass at time of cesarean section.

Figure 2: Metastatic disease noted on the liver.

elevated from her baseline blood pressures. The patient also
had complaints of headache, back pain, nausea, and vomiting.
Postpartum preeclampsia was considered the likely diagnosis.
Laboratory studies were drawn and showed the following:
aminotransferase elevated at 89 U/L, alanine transaminase
at 26 U/L, creatinine at 55.6 𝜇mol/L, and LDH elevated at
22.3 𝜇kat/L. The patient was transferred back to labor and
delivery and started on magnesium sulfate for postpartum
preeclampsia and also labetalol 200 mg three times daily.
The patient’s blood pressures stabilized on antihypertensive medications, which were discontinued after twentyfour hours because of normalization of blood pressures.
Her laboratory findings remained abnormal for an elevated
aspartate aminotransferase ranging between 73 and 110 U/L
and also an elevated LDH between 23 and 33 𝜇kat/L. The
patient later spiked temperatures up to 39∘ C. She was started
on broad-spectrum antibiotics for postpartum endometritis.
Blood cultures and urine cultures were obtained. The urine
culture returned as positive for Pseudomonas aeruginosa,
and the blood cultures were positive for Klebsiella pneumoniae. Broad-spectrum antibiotics were discontinued and
the patient was started on cefepime. Per infectious disease
consult, a renal ultrasound was also obtained to evaluate for
pyelonephritis and nephrolithiasis.
Renal ultrasound showed normal kidneys and bladder
and revealed a large solid hepatic mass with a central cystic
component measuring 9.4 × 8.1 × 14.0 cm. A CT scan revealed
large confluent hypodense masses involving the right and left
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hepatic lobes and enlarged retroperitoneal and mesenteric
lymph nodes. A persistently thickened segment of the distal
ascending colon/proximal pelvic flexure was also noted.
There were no findings of metastatic process in the chest.
Hepatology was consulted and further laboratory studies
were obtained including cancer antigen (CA) 125: 67 kU/L;
alpha-fetoprotein: 34.2; CEA: 552.3 mcg/L; and CA 19-9 at
23608 kU/L. Further work-up was recommended to differentiate between breast, ovarian, pancreatic, or colonic primary
cancers. Screening mammography was within normal limits.
A CT guided liver biopsy ultimately confirmed adenocarcinoma of colonic origin. A colonoscopy was performed, which
showed a friable mass in the ascending colon. A biopsy of
the mass also showed adenocarcinoma. Kras was ordered
and was mutated. Diagnosis of stage IV colon cancer was
confirmed. The patient started palliative chemotherapy with
FOLFOX after being discharged from the hospital.

3. Discussion
CRC is one of the most common types of cancer in women.
While the highest incidence of CRC occurs in patients aged
50 years or older, 3% of patients with CRC are younger than
40 years of age and it is the seventh most common type of
cancer in pregnancy with a reported incidence of 0.002%.
[1–3]. The median age in reported cases of diagnosis was 31
years, with most cases being reported in very advanced stages
due to diagnostic challenges [1, 3]. The presenting signs and
symptoms of CRC include nausea, vomiting, abdominal pain,
altered bowel movements, rectal bleeding, and anemia which
can be commonly found in pregnancy. Due to this reason,
many of these signs and symptoms are typically overlooked
and an appropriate work-up is not initiated until the cancer
is already in advanced stages [1–5]. In our second case, the
diagnosis of colon cancer was an incidental finding while
evaluating the kidneys due to a urinary tract infection and
bacteremia with the patient only complaining of nausea,
vomiting, and back pain during her third trimester.
Signs and symptoms of CRC in pregnancy such as
persistent rectal bleeding, nausea and vomiting, constipation,
and weight loss should be worked up. Hemorrhoids, the
common cause of rectal bleeding, should be visualized and
rectal examination should be performed when a patient
presents with a complaint of rectal bleeding. In addition, if
a patient starts to lose weight while pregnant, she should be
evaluated for maternal and fetal etiologies. Persistent nausea
and vomiting in pregnancy should be evaluated further,
especially in the third trimester [1–6].
Treatment goals of the mother take into account the
gestational age of the fetus, fetal lung maturity, cancer stage,
and the need for emergent or elective surgery. The goal is
to start treatment for the mother as early as possible. If
the cancer is detected at a more advanced gestational age,
delivery of the viable infant can occur at 32 weeks if the lungs
are matured [6]. Treatment modalities may include surgery,
radiation therapy, and chemotherapy depending on the stage
of the cancer [6].
Pregnant women with colorectal cancer generally have a
poor prognosis due to the late diagnosis of the disease. In
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a review of 42 patients with colorectal cancer in the literature,
Chan et al. noted that 23 (56%) of these patients died by the
time the cases were reported in the literature [2, 7]. Most died
within fifteen months of diagnosis and the median survival
for the group was less than 5 months. One patient survived
3.5 years after bowel resection with multiple recurrences. No
patient with colorectal cancer in pregnancy in the literature
has survived longer than five years [2, 7].
In conclusion, CRC is an aggressive cancer that is rarely
found in pregnancy. However, when CRC is found in pregnancy it is usually diagnosed in the late stages. Early diagnosis
improves survival and treatment outcomes. Thorough physical examination should be performed on patients presenting
in the early first trimester before the gravid uterus becomes
prominent with special attention given to the gastrointestinal
evaluation, which should include the evaluation of the size
of the liver and a rectal examination to screen for masses.
Common physiological symptoms of pregnancy should be
scrutinized carefully and worked up appropriately, especially
if symptoms remain persistent or increase in intensity or
severity. A thorough evaluation of abnormal laboratory
values and consideration of nonobstetric disease processes
is important to optimize patient outcomes in complicated
obstetric patients.
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